Mar 6, 2025, 01:00 AM by User Not Found

Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families.

Mar 5, 2025, 08:14 AM by

Today, in partnership with ScienceMachine, FutureHouse is introducing BixBench, a benchmark designed to evaluate AI agents on real-world bioinformatics tasks. BixBench challenges AI models with open-ended analytical research scenarios, requiring them to analyze data, generate insights, and interpret results autonomously.

Mar 5, 2025, 08:14 AM by

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Mar 5, 2025, 01:00 AM by User Not Found

Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.

Mar 4, 2025, 01:00 AM by User Not Found

Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.

Feb 28, 2025, 08:10 AM by

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

Feb 28, 2025, 01:00 AM by User Not Found

Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.

Feb 27, 2025, 10:28 AM by

Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking

Feb 27, 2025, 10:28 AM by

Biocair, an established global leader in life science logistics, announces the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.

Feb 27, 2025, 09:20 AM by User Not Found

Bio-IT World| InfoBionic.Ai’s MoMe ARC delivers real-time cardiac insights, empowering physicians to improve patient outcomes; Ultima Genomics announced the commercial launch of UG 100 Solaris; and more.

Feb 26, 2025, 08:13 AM by User Not Found

Bio-IT World| Stellaromics commercializes their 3D spatial biology platform, Pyxa; Latent Labs’ AI platform shows promising potential to open new paths to personalized medicines; and more.

Feb 25, 2025, 08:07 AM by

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

Feb 25, 2025, 08:07 AM by

Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.

Feb 25, 2025, 08:07 AM by

Vector Laboratories has appointed Ashley Scholz as its new Vice President of Marketing. Ashley brings 16+ years of experience in medical devices, cancer diagnostics, and molecular diagnostics, most recently leading marketing at W.L. Gore & Associates.

Feb 24, 2025, 08:06 AM by

Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).

Feb 21, 2025, 08:19 AM by

Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.

Feb 21, 2025, 08:19 AM by

Feb 20, 2025, 08:27 AM by

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

Feb 20, 2025, 08:27 AM by

Feb 20, 2025, 08:27 AM by